Active Rheumatoid Arthritis Clinical Trial
Official title:
A Phase IIIB Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess Short-term Changes in Synovitis and Structural Damage Outcomes in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate, Treated With Abatacept Versus Placebo on a Background Therapy With Methotrexate
The only trial in participants who are methotrexate-inadequate responders and have active Rheumatoid Arthritis, in which gadolinium-enhanced Magnetic Resonance Imaging; Bone Mineral Density; and biochemical markers of bone, cartilage, and synovial tissue metabolism are used to evaluate early effects (4 months) of Abatacept on inflammation/structural damage. Study will provide valuable mechanism-of-action information on how Abatacept exerts its effects (including on bone) through new techniques.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04472481 -
Vitamin D Effect in Rheumatoid Arthritis.
|
Phase 4 | |
| Completed |
NCT00913458 -
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
|
Phase 4 | |
| Completed |
NCT00959036 -
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
|
Phase 1/Phase 2 | |
| Completed |
NCT01961505 -
Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis
|
N/A | |
| Completed |
NCT00393471 -
Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
|
Phase 3 | |
| Not yet recruiting |
NCT03346590 -
Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects
|
N/A | |
| Terminated |
NCT02534896 -
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
|
Phase 3 | |
| Completed |
NCT03172325 -
Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
|
Phase 3 | |
| Completed |
NCT00882024 -
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
|
Phase 2 | |
| Completed |
NCT03599986 -
Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
|
||
| Completed |
NCT02586246 -
Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870
|
Phase 3 | |
| Completed |
NCT01008852 -
Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
|
Phase 2 |